Status:

COMPLETED

Feasibility and Effect of a Strategy-Based Cognitive Intervention for Parkinson Disease

Lead Sponsor:

Washington University School of Medicine

Collaborating Sponsors:

National Institute on Aging (NIA)

Conditions:

Parkinson Disease

Eligibility:

All Genders

40+ years

Phase:

NA

Brief Summary

Parkinson disease (PD) affects over 1 million Americans and causes considerable personal and socioeconomic costs (\>$34 billion/year in the US) that are expected to rise as the population ages. Cognit...

Detailed Description

Parkinson disease (PD) affects over 1 million Americans and causes considerable personal and socioeconomic costs (\>$34 billion/year in the US) that are expected to rise as the population ages. Cognit...

Eligibility Criteria

Inclusion

  • males and females over age 40 who meet criteria for typical idiopathic PD (stage I-III)
  • Have subjective cognitive decline (SCD) as defined by a positive answer to either question: "Do you feel like your thinking skills or memory are becoming worse?" "Do you have problems with your thinking skills or memory?", and can list one or more daily cognitive challenge they wish to address.
  • Medications should be stable for 4 weeks prior with no changes planned during the study (we will document unplanned changes).

Exclusion

  • Dementia according to MDS criteria or a Montreal Cognitive Assessment (MoCA) score \< 21
  • other neurological disorders
  • brain surgery
  • history of psychotic disorder
  • any condition that would interfere with participation (e.g. non-English speaking, significant current depression)

Key Trial Info

Start Date :

November 4 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2022

Estimated Enrollment :

57 Patients enrolled

Trial Details

Trial ID

NCT04048122

Start Date

November 4 2019

End Date

July 1 2022

Last Update

November 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Washington University School of Medicine, Movement Disorders Center

St Louis, Missouri, United States, 63110